X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.760
+0.010 (0.27%)
At close: Jan 22, 2026, 4:00 PM EST
3.750
-0.010 (-0.27%)
After-hours: Jan 22, 2026, 5:07 PM EST
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $328.76 million as of January 22, 2026. Its market cap has increased by 159.76% in one year.
Market Cap
328.76M
Enterprise Value
286.55M
1-Year Change
159.76%
Ranking
Category
Stock Price
$3.76
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $328.76M, an increase of 223.03%. That is a compound annual growth rate of 18.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 327.89M | -6.25% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 352.61M |
| Aura Biosciences | 348.00M |
| Puma Biotechnology | 347.19M |
| Candel Therapeutics | 345.86M |
| Aardvark Therapeutics | 344.45M |
| XOMA Royalty | 337.69M |
| AC Immune | 336.41M |
| Neumora Therapeutics | 331.38M |